Annual Shareholders Equity
-$8.21 M
+$6.23 M+43.14%
December 31, 2023
Summary
- As of February 7, 2025, CDTX annual stockholders equity is -$8.21 million, with the most recent change of +$6.23 million (+43.14%) on December 31, 2023.
- During the last 3 years, CDTX annual shareholders equity has fallen by -$18.93 million (-176.62%).
- CDTX annual shareholders equity is now -107.90% below its all-time high of $103.91 million, reached on December 31, 2015.
Performance
CDTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$115.63 M
-$15.31 M-11.69%
September 30, 2024
Summary
- As of February 7, 2025, CDTX quarterly stockholders equity is $115.63 million, with the most recent change of -$15.31 million (-11.69%) on September 30, 2024.
- Over the past year, CDTX quarterly shareholders equity has increased by +$123.84 million (+1508.40%).
- CDTX quarterly shareholders equity is now -11.69% below its all-time high of $130.94 million, reached on June 30, 2024.
Performance
CDTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CDTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.1% | +1508.4% |
| 3 y3 years | -176.6% | +330.9% |
| 5 y5 years | -113.9% | +330.9% |
CDTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -138.1% | +43.1% | -11.7% | +750.3% |
| 5 y | 5-year | -121.7% | +43.1% | -11.7% | +750.3% |
| alltime | all time | -107.9% | +43.1% | -11.7% | +750.3% |
Cidara Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $115.63 M(-11.7%) |
| Jun 2024 | - | $130.94 M(-836.4%) |
| Mar 2024 | - | -$17.78 M(+116.6%) |
| Dec 2023 | -$8.21 M(-43.1%) | -$8.21 M(-202.1%) |
| Sep 2023 | - | $8.04 M(-47.9%) |
| Jun 2023 | - | $15.41 M(-42.6%) |
| Mar 2023 | - | $26.84 M(-285.9%) |
| Dec 2022 | -$14.44 M(-166.9%) | -$14.44 M(-259.2%) |
| Sep 2022 | - | $9.07 M(-213.9%) |
| Jun 2022 | - | -$7.96 M(-260.6%) |
| Mar 2022 | - | $4.96 M(-77.0%) |
| Dec 2021 | $21.57 M(+101.3%) | $21.57 M(-1963.0%) |
| Sep 2021 | - | -$1.16 M(-107.3%) |
| Jun 2021 | - | $15.79 M(+734.5%) |
| Mar 2021 | - | $1.89 M(-82.3%) |
| Dec 2020 | $10.71 M(-71.7%) | $10.71 M(-63.7%) |
| Sep 2020 | - | $29.55 M(-28.5%) |
| Jun 2020 | - | $41.35 M(-23.1%) |
| Mar 2020 | - | $53.75 M(+42.1%) |
| Dec 2019 | $37.84 M | $37.84 M(-22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $48.96 M(+54.1%) |
| Jun 2019 | - | $31.78 M(-27.5%) |
| Mar 2019 | - | $43.86 M(-25.8%) |
| Dec 2018 | $59.14 M(-1.0%) | $59.14 M(-15.4%) |
| Sep 2018 | - | $69.93 M(-14.9%) |
| Jun 2018 | - | $82.14 M(+61.3%) |
| Mar 2018 | - | $50.92 M(-14.8%) |
| Dec 2017 | $59.74 M(-32.2%) | $59.74 M(+18.1%) |
| Sep 2017 | - | $50.57 M(-17.5%) |
| Jun 2017 | - | $61.26 M(-19.4%) |
| Mar 2017 | - | $75.99 M(-13.8%) |
| Dec 2016 | $88.18 M(-15.1%) | $88.18 M(+19.3%) |
| Sep 2016 | - | $73.92 M(-12.8%) |
| Jun 2016 | - | $84.81 M(-10.8%) |
| Mar 2016 | - | $95.08 M(-8.5%) |
| Dec 2015 | $103.91 M(-1007.9%) | $103.91 M(-7.7%) |
| Sep 2015 | - | $112.63 M(-6.8%) |
| Jun 2015 | - | $120.86 M(-789.6%) |
| Mar 2015 | - | -$17.53 M(+53.1%) |
| Dec 2014 | -$11.45 M(+718.7%) | -$11.45 M |
| Dec 2013 | -$1.40 M | - |
FAQ
- What is Cidara Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Cidara Therapeutics?
- What is Cidara Therapeutics annual shareholders equity year-on-year change?
- What is Cidara Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly shareholders equity year-on-year change?
What is Cidara Therapeutics annual stockholders equity?
The current annual shareholders equity of CDTX is -$8.21 M
What is the all time high annual shareholders equity for Cidara Therapeutics?
Cidara Therapeutics all-time high annual stockholders equity is $103.91 M
What is Cidara Therapeutics annual shareholders equity year-on-year change?
Over the past year, CDTX annual stockholders equity has changed by +$6.23 M (+43.14%)
What is Cidara Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CDTX is $115.63 M
What is the all time high quarterly shareholders equity for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly stockholders equity is $130.94 M
What is Cidara Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CDTX quarterly stockholders equity has changed by +$123.84 M (+1508.40%)